Market Cap 15.47B
Revenue (ttm) 5.14B
Net Income (ttm) -510.63M
EPS (ttm) N/A
PE Ratio 20.97
Forward PE 9.81
Profit Margin -9.93%
Debt to Equity Ratio 0.19
Volume 2,424,700
Avg Vol 2,427,674
Day's Range N/A - N/A
Shares Out 118.01M
Stochastic %K 90%
Beta 1.33
Analysts Strong Sell
Price Target $187.27

Company Profile

Albemarle Corporation provides energy storage solutions worldwide. It operates through three segments: Energy Storage, Specialties, and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride for use in lithium batteries used in consumer electronics and electric vehicles; power grids and solar panels; high-performance greases; and specialty glass used in consumer appliances and electronics. The Specialties segment provides...

Industry: Specialty Chemicals
Sector: Basic Materials
Phone: 980 299 5700
Fax: 980 299 5512
Address:
4250 Congress Street, Suite 900, Charlotte, United States
Dawgin
Dawgin Aug. 10 at 4:41 PM
Trump #LI roundtable a little disappointing in my opinion. Ws hoping for more investment than $3B. $IONR, $ALB, $LAC
0 · Reply
CapitalMonk
CapitalMonk Aug. 10 at 4:32 PM
$ALB Price: $130.86 (-0.19%) Trend: Bearish Market Bias (7D): Bearish Bias 📉 Expected Range: ±2.01% RSI: 70.1 | Momentum: Strong Momentum Volume: -63.2% vs avg Volatility: 2.52% Support: $111.55 | Resistance: $133.21 Data and analytics sourced from Thescanner educational research https://www.thescanner.ai
0 · Reply
NebulaArb
NebulaArb Aug. 10 at 3:29 PM
$ALB $AVAV $TECL $CASHCAT $NDAQ Albemarle remains tied to lithium and battery-material demand, AeroVironment benefits from defense-drone spending, TECL provides leveraged technology exposure, CASHCAT remains highly speculative, and Nasdaq benefits from trading and market activity. I'm watching lithium prices, defense contracts, technology momentum, liquidity, and trading volumes.
0 · Reply
Options_Destroyer
Options_Destroyer Aug. 10 at 2:25 PM
0 · Reply
TheRichFuller
TheRichFuller Aug. 10 at 2:12 PM
$AA and $ALB building out of a washout
0 · Reply
Advance33
Advance33 Aug. 10 at 1:37 PM
0 · Reply
GreyZone
GreyZone Aug. 10 at 9:07 AM
$ALB Wow Up in pre market 🟢
0 · Reply
ContrarianLife
ContrarianLife Aug. 9 at 5:36 PM
0 · Reply
iTrade_Price
iTrade_Price Aug. 9 at 3:12 PM
$ALB -- nice push higher from the recent lows.
0 · Reply
SuperGreenToday
SuperGreenToday Aug. 8 at 12:30 AM
$ALB Share Price: $131.21 Contract Selected: Sep 04, 2026 $130 Calls Buy Zone: $6.54 – $8.09 Target Zone: $11.07 – $13.54 Potential Upside: 60% ROI Time to Expiration: 27 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Latest News on ALB
Albemarle price target lowered to $190 from $200 at Scotiabank

2026-08-10T11:55:34.000Z - 17 hours ago

Albemarle price target lowered to $190 from $200 at Scotiabank


Albemarle price target lowered to $225 from $245 at Truist

2026-08-07T14:05:34.000Z - 3 days ago

Albemarle price target lowered to $225 from $245 at Truist


Albemarle price target lowered to $175 from $205 at UBS

2026-08-07T13:01:57.000Z - 3 days ago

Albemarle price target lowered to $175 from $205 at UBS


Albemarle price target lowered to $175 from $225 at Citi

2026-08-07T11:13:00.000Z - 3 days ago

Albemarle price target lowered to $175 from $225 at Citi


Albemarle Earnings Call Transcript: Q2 2026

Aug 6, 2026, 8:00 AM EDT - 4 days ago

Albemarle Earnings Call Transcript: Q2 2026


Albemarle Earnings release: Q2 2026

Aug 6, 2026, 8:00 AM EDT - 4 days ago

Albemarle Earnings release: Q2 2026


Albemarle Slides: Q2 2026

Aug 6, 2026, 8:00 AM EDT - 4 days ago

Albemarle Slides: Q2 2026


Albemarle Quarterly report: Q2 2026

Aug 6, 2026, 8:00 AM EDT - 4 days ago

Albemarle Quarterly report: Q2 2026


Albemarle price target lowered to $160 from $185 at Mizuho

2026-08-06T11:16:38.000Z - 4 days ago

Albemarle price target lowered to $160 from $185 at Mizuho


Albemarle reports Q2 adjusted EPS $3.75, consensus $3.24

2026-08-05T20:28:02.000Z - 5 days ago

Albemarle reports Q2 adjusted EPS $3.75, consensus $3.24


Albemarle Reports Second Quarter 2026 Results

Aug 5, 2026, 4:15 PM EDT - 5 days ago

Albemarle Reports Second Quarter 2026 Results


Albemarle Appoints Eduardo Bartolomeo to Board of Directors

Jul 23, 2026, 4:15 PM EDT - 18 days ago

Albemarle Appoints Eduardo Bartolomeo to Board of Directors


Albemarle Announces Quarterly Common Stock Dividend

Jul 21, 2026, 4:15 PM EDT - 20 days ago

Albemarle Announces Quarterly Common Stock Dividend


Albemarle price target lowered to $155 from $225 at BofA

2026-07-17T12:55:18.000Z - 24 days ago

Albemarle price target lowered to $155 from $225 at BofA


Albemarle price target lowered to $185 from $205 at Mizuho

2026-07-01T11:11:27.000Z - 5 weeks ago

Albemarle price target lowered to $185 from $205 at Mizuho


Albemarle upgraded to Buy from Neutral at Citi

2026-06-18T09:35:21.000Z - 7 weeks ago

Albemarle upgraded to Buy from Neutral at Citi


Albemarle Slides: Investor presentation

May 20, 2026, 7:00 AM EDT - 2 months ago

Albemarle Slides: Investor presentation


Albemarle Earnings Call Transcript: Q1 2026

May 7, 2026, 8:00 AM EDT - 3 months ago

Albemarle Earnings Call Transcript: Q1 2026


Albemarle Earnings release: Q1 2026

May 7, 2026, 8:00 AM EDT - 3 months ago

Albemarle Earnings release: Q1 2026


Albemarle Quarterly report: Q1 2026

May 7, 2026, 8:00 AM EDT - 3 months ago

Albemarle Quarterly report: Q1 2026


Albemarle Slides: Q1 2026

May 7, 2026, 8:00 AM EDT - 3 months ago

Albemarle Slides: Q1 2026


Albemarle Reports First Quarter 2026 Results

May 6, 2026, 4:15 PM EDT - 3 months ago

Albemarle Reports First Quarter 2026 Results


Albemarle Proxy statement: Proxy filing

Mar 24, 2026, 8:00 AM EDT - 4 months ago

Albemarle Proxy statement: Proxy filing


Albemarle Proxy statement: Proxy filing

Mar 24, 2026, 8:00 AM EDT - 4 months ago

Albemarle Proxy statement: Proxy filing


Albemarle Proxy statement: Proxy Filing

Mar 11, 2026, 8:00 AM EDT - 5 months ago

Albemarle Proxy statement: Proxy Filing


Albemarle Slides: Investor presentation

Mar 11, 2026, 7:00 AM EDT - 5 months ago

Albemarle Slides: Investor presentation


Albemarle Appoints Michelle T. Collins and Mark R.

Mar 2, 2026, 4:40 PM EST - 5 months ago

Albemarle Appoints Michelle T. Collins and Mark R.


Albemarle Earnings Call Transcript: Q4 2025

Feb 12, 2026, 8:00 AM EST - 6 months ago

Albemarle Earnings Call Transcript: Q4 2025


Albemarle Annual report: Q4 2025

Feb 12, 2026, 8:00 AM EST - 6 months ago

Albemarle Annual report: Q4 2025


Albemarle Earnings release: Q4 2025

Feb 12, 2026, 8:00 AM EST - 6 months ago

Albemarle Earnings release: Q4 2025


Albemarle Slides: Q4 2025

Feb 12, 2026, 8:00 AM EST - 6 months ago

Albemarle Slides: Q4 2025


Albemarle Reports Fourth Quarter and Full Year 2025 Results

Feb 11, 2026, 4:15 PM EST - 6 months ago

Albemarle Reports Fourth Quarter and Full Year 2025 Results


Lithium Spike Behind ALB Upgrade, FSLR & DECK Downgrades

Jan 7, 2026, 10:00 AM EST - 7 months ago

Lithium Spike Behind ALB Upgrade, FSLR & DECK Downgrades

FSLR DECK


Albemarle Stock Soars. It's the Robots.

Jan 6, 2026, 12:20 PM EST - 7 months ago

Albemarle Stock Soars. It's the Robots.


These Five Stocks Could Get a Government Boost

Nov 17, 2025, 2:40 PM EST - 9 months ago

These Five Stocks Could Get a Government Boost

AMKR LAC MP WOLF


MP Materials, Rare Earth Stocks Fall—Again

Nov 17, 2025, 11:47 AM EST - 9 months ago

MP Materials, Rare Earth Stocks Fall—Again

LAC MP TMQ USAR UUUU


Albemarle Earnings Call Transcript: Q3 2025

Nov 6, 2025, 8:00 AM EST - 9 months ago

Albemarle Earnings Call Transcript: Q3 2025


Albemarle Quarterly report: Q3 2025

Nov 6, 2025, 8:00 AM EST - 9 months ago

Albemarle Quarterly report: Q3 2025


Albemarle Earnings release: Q3 2025

Nov 6, 2025, 8:00 AM EST - 9 months ago

Albemarle Earnings release: Q3 2025


Albemarle Slides: Q3 2025

Nov 6, 2025, 8:00 AM EST - 9 months ago

Albemarle Slides: Q3 2025


Albemarle Reports Third Quarter 2025 Results

Nov 5, 2025, 4:15 PM EST - 9 months ago

Albemarle Reports Third Quarter 2025 Results


How the US-China trade deal impacts rare earth stocks

Nov 2, 2025, 10:28 AM EST - 10 months ago

How the US-China trade deal impacts rare earth stocks

LAC MP TMQ USAR UUUU


China & U.S. "Truce:" Rare Earth Stocks & Energy Take Focus

Oct 30, 2025, 10:30 AM EDT - 10 months ago

China & U.S. "Truce:" Rare Earth Stocks & Energy Take Focus

LAC MP TMQ USAR UUUU


Rare Earth Stocks Pullback on China/U.S. Talks

Oct 27, 2025, 2:45 PM EDT - 10 months ago

Rare Earth Stocks Pullback on China/U.S. Talks

LAC MP TMQ USAR UUUU


Dawgin
Dawgin Aug. 10 at 4:41 PM
Trump #LI roundtable a little disappointing in my opinion. Ws hoping for more investment than $3B. $IONR, $ALB, $LAC
0 · Reply
CapitalMonk
CapitalMonk Aug. 10 at 4:32 PM
$ALB Price: $130.86 (-0.19%) Trend: Bearish Market Bias (7D): Bearish Bias 📉 Expected Range: ±2.01% RSI: 70.1 | Momentum: Strong Momentum Volume: -63.2% vs avg Volatility: 2.52% Support: $111.55 | Resistance: $133.21 Data and analytics sourced from Thescanner educational research https://www.thescanner.ai
0 · Reply
NebulaArb
NebulaArb Aug. 10 at 3:29 PM
$ALB $AVAV $TECL $CASHCAT $NDAQ Albemarle remains tied to lithium and battery-material demand, AeroVironment benefits from defense-drone spending, TECL provides leveraged technology exposure, CASHCAT remains highly speculative, and Nasdaq benefits from trading and market activity. I'm watching lithium prices, defense contracts, technology momentum, liquidity, and trading volumes.
0 · Reply
Options_Destroyer
Options_Destroyer Aug. 10 at 2:25 PM
0 · Reply
TheRichFuller
TheRichFuller Aug. 10 at 2:12 PM
$AA and $ALB building out of a washout
0 · Reply
Advance33
Advance33 Aug. 10 at 1:37 PM
0 · Reply
GreyZone
GreyZone Aug. 10 at 9:07 AM
$ALB Wow Up in pre market 🟢
0 · Reply
ContrarianLife
ContrarianLife Aug. 9 at 5:36 PM
0 · Reply
iTrade_Price
iTrade_Price Aug. 9 at 3:12 PM
$ALB -- nice push higher from the recent lows.
0 · Reply
SuperGreenToday
SuperGreenToday Aug. 8 at 12:30 AM
$ALB Share Price: $131.21 Contract Selected: Sep 04, 2026 $130 Calls Buy Zone: $6.54 – $8.09 Target Zone: $11.07 – $13.54 Potential Upside: 60% ROI Time to Expiration: 27 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
BPID
BPID Aug. 7 at 8:06 PM
$ALB Solid attempt at a recovery for us on better than expected earnings. Gotta love it… hope y’all bought that dip! Next week, inflation data on deck.
0 · Reply
InItToWinIt100
InItToWinIt100 Aug. 7 at 7:24 PM
0 · Reply
Options_Destroyer
Options_Destroyer Aug. 7 at 5:06 PM
$AA we're finally beaking out $CCJ $ALB my babies.. long overdue
1 · Reply
drewkaiser
drewkaiser Aug. 7 at 4:31 PM
$GMGMF Tangential to GMG, but you'll see some parallels. https://youtu.be/RUk3OCKFzBY?si=J7BhakZk7HkE591T Metallium $MTMCF. They will be pulling gold out of electronic waste. They will pull rare earths from mine tailings, especially red mud (toxic, noxious mine waste). They'll be getting at lithium. They got A LOT going on. $ABAT $LLKKF $ALB
2 · Reply
PackBagger
PackBagger Aug. 7 at 3:08 PM
$ALB Sorry for being few days late
0 · Reply
BPID
BPID Aug. 7 at 3:04 PM
$ALB Average price target drops from $192.22 to $188.06. 4 pts. A few weeks of rising lithium prices and we’ll be right where we want to be. Demand is there, sentiment hasn’t caught up.
0 · Reply
Leilafishes
Leilafishes Aug. 7 at 2:10 PM
$ALB one of my bigger positions. Sub 60 average. Big rejection at open. Thought we might have ended the downtrend but that price action is no bueno.
1 · Reply
ContrarianLife
ContrarianLife Aug. 7 at 1:56 PM
$ALB Oh come on. $6 off high?
1 · Reply
McReethie
McReethie Aug. 7 at 1:33 PM
Who do you think is at the round table? $ABAT $LAC $IONR $ALB https://www.tradeapes.com/stocks/ALB
0 · Reply
ContrarianLife
ContrarianLife Aug. 7 at 12:42 PM
$ALB Bee line to $180 within 60 days.
1 · Reply
GreyZone
GreyZone Aug. 7 at 10:18 AM
$ALB Anyone? Nice & Clean retesting prior breakout -Good S/R Flip setup
0 · Reply
ChristinaCarpenter489
ChristinaCarpenter489 Aug. 7 at 9:24 AM
$MCHP $PDYN $BCRX $TGTX $ALB Microchip Technology benefits from industrial semiconductor demand, PDYN remains speculative, BioCryst advances rare disease treatments, TG Therapeutics continues expanding its multiple sclerosis franchise, and Albemarle remains leveraged to long-term lithium demand. I'm watching commercial execution and industry fundamentals.
0 · Reply